Evidence map›Paper›PMID 24089267›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2014

Inhibition of the Ca(2+)-sensing receptor rescues pulmonary hypertension in rats and mice.

Qiang Guo, Jian-An Huang, Aya Yamamura, Hisao Yamamura, Adriana M Zimnicka, Ruby Fernandez, Jason X-J Yuan

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Signaling pathways and targeted therapy for pulmonary hypertension.Signal transduction and targeted therapy · 2025
    Review
  3. Growth factors involved in vascular remodeling in pulmonary arterial hypertension.Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi · 2025
    Review
  4. Review
  5. A novel function of calcium sensing receptor in chronic hypoxia-induced pulmonary venous smooth muscle cells proliferation.Hypertension research : official journal of the Japanese Society of Hypertension · 2020
    Article
  6. Article
  7. Notch activation of CaHypertension research : official journal of the Japanese Society of Hypertension · 2017
    Article
  8. Review
  9. Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension.American journal of respiratory and critical care medicine · 2016
    Article
  10. Reversal of right ventricular remodeling by dichloroacetate is related to inhibition of mitochondria-dependent apoptosis.Hypertension research : official journal of the Japanese Society of Hypertension · 2016
    Article
  11. The vascular Ca2+-sensing receptor regulates blood vessel tone and blood pressure.American journal of physiology. Cell physiology · 2016
    Article
  12. Article
  13. Intravenous fasudil improves in-hospital mortality of patients with right heart failure in severe pulmonary hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2015
    Article
  14. Article
  15. Article
  16. Pathological function of Ca2+-sensing receptor in pulmonary arterial hypertension.Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Qiang GuoDepartment of Medicine, Respiratory, Infectious, Emergency and Intensive Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
Jian-An HuangDepartment of Medicine, Respiratory, Infectious, Emergency and Intensive Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
Aya Yamamura1] Section of Pulmonary, Critical Care, Sleep and Allergy Medicine, Department of Medicine, Institute for Personalized Respiratory Medicine, Chicago, IL, USA [2] Department of Pharmacology, Center for Cardiovascular Research, University of Illinois at Chicago, Chicago, IL, USA.
Hisao Yamamura1] Section of Pulmonary, Critical Care, Sleep and Allergy Medicine, Department of Medicine, Institute for Personalized Respiratory Medicine, Chicago, IL, USA [2] Department of Pharmacology, Center for Cardiovascular Research, University of Illinois at Chicago, Chicago, IL, USA.
Adriana M Zimnicka1] Section of Pulmonary, Critical Care, Sleep and Allergy Medicine, Department of Medicine, Institute for Personalized Respiratory Medicine, Chicago, IL, USA [2] Department of Pharmacology, Center for Cardiovascular Research, University of Illinois at Chicago, Chicago, IL, USA.
Ruby Fernandez1] Section of Pulmonary, Critical Care, Sleep and Allergy Medicine, Department of Medicine, Institute for Personalized Respiratory Medicine, Chicago, IL, USA [2] Department of Pharmacology, Center for Cardiovascular Research, University of Illinois at Chicago, Chicago, IL, USA.
Jason X-J Yuan1] Section of Pulmonary, Critical Care, Sleep and Allergy Medicine, Department of Medicine, Institute for Personalized Respiratory Medicine, Chicago, IL, USA [2] Department of Pharmacology, Center for Cardiovascular Research, University of Illinois at Chicago, Chicago, IL, USA.
Soochow University · CN

Funding

Systems Biology CoreP01HL098053 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI POWELL, FRANK L. · 2010 to 2014
$10.2M
Capacitative Ca2+ Entry in Pulmonary Myocyte GrowthR01HL066012 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI YUAN, JASON X J · 2002 to 2016
$5.2M
NHLBI NIH HHS HL066012NHLBI NIH HHS HL098053NHLBI NIH HHS P01 HL098053NHLBI NIH HHS R01 HL066012
6 · The paper itself

Abstract

A recent study from our group demonstrated that the Ca(2+)-sensing receptor (CaSR) was upregulated, and the extracellular Ca(2+)-induced increase in cytosolic Ca(2+) concentration ([Ca(2+)]cyt) was enhanced in pulmonary arterial smooth muscle cells from patients with idiopathic pulmonary arterial hypertension and animals with experimental pulmonary hypertension (PH). However, it is unclear whether CaSR antagonists (for example, NPS2143) rescue the development of experimental PH. We tested the rescue effects of NPS2143 in rats with monocrotaline (MCT)-induced PH and mice with chronic hypoxia-induced PH. For the NPS2143 treatment group, rats and mice were i.p. injected with NPS2143 once per day from days 14 to 24. Four weeks after MCT injection or exposure to normobaric hypoxia, the right ventricular (RV) systolic pressure, right heart hypertrophy (RV/LV+S ratio) and RV myocardial fibrosis were rescued or nearly restored to normal levels by NPS2143 treatment. The rescue effects of NPS2143 on experimental PH further support a critical role for the CaSR in the PH mechanism. Therefore, NPS2143 may be a promising potential treatment for pulmonary arterial hypertension.

Indexed as

AnimalsBlotting, WesternCalciumFibrosisHemodynamicsHypertension, PulmonaryHypertrophy, Right VentricularMaleMiceMice, Inbred C57BLMonocrotalineMyocardiumPoisonsPulmonary ArteryRatsRats, Sprague-DawleyCalciumMonocrotalinePoisonsReceptors, Calcium-Sensing

Identifiers

PMID24089267
PMCPMC5524516
OpenAlexW2035229995

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.